Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 1150620190030010008
Biomedical Dermatology
2019 Volume.3 No. 1 p.8 ~ p.8
Trichogenic effect of topical ketoconazole versus minoxidil 2% in female pattern hair loss: a clinical and trichoscopic evaluation
El-Garf Ahmed

Mohie Mohamed
Salah Eman
Abstract
Background: Female pattern hair loss (FPHL) is a common non-scaring alopecia. Topical minoxidil is the only approved treatment for FPHL; however, it has frequent side effects. Ketoconazole is an antifungal with anti-androgenic properties.

Methods: The aim of this work was to evaluate the safety and possible trichogenic effects of ketoconazole in FPHL. Patients were randomly assigned into Group A with 20 patients who received 2% topical minoxidil solution and Group B involving 20 patients who were treated by 2% topical ketoconazole preparation. All patients were treated for 6?months and evaluated clinically plus via trichoscopy. Side effects were recorded, and patients¡¯ satisfaction was measured.

Results: Regarding hair growth, a significant difference was detected between baseline and at 4th and 6th months in Group A. While in Group B, the improvement was delayed until the 6th month. Only 10% of Group B reported side effects. Patients¡¯ satisfaction did not differ between the two groups.

Conclusions: Topical ketoconazole mediates a trichogenic effect in FPHL with few side effects. However, ketoconazole showed a delayed improvement versus minoxidil at similar concentrations. Further studies should evaluate the efficacy of higher concentrations of ketoconazole solutions for FPHL which is a promising therapy.
KEYWORD
Ketoconazole, Minoxidil, FPHL, Alopecia, Trichoscopy
FullTexts / Linksout information
 
Listed journal information